Dr Lal Path Labs rose 6.20% to Rs 2,118, extending gains for the third straight session.
Shares of Dr Lal Path Labs soared 13.84% in three trading sessions from a recent closing low of Rs 1,860.35 hit on 1 October 2020.
The diagnostic services provider consolidated net profit tanked 51.9% to Rs 28.40 crore on 20.6% decline in net sales to Rs 266 crore in Q1 June 2020 over Q1 June 2019.
Dr. Lal PathLabs is a provider of diagnostic and related healthcare tests and services in India. As on 31 March 2020 the company has 216 clinical laboratories (including National Reference Lab at Delhi & Regional Reference Lab at Kolkata), 3,095 Patient Service Centers (PSCs) and 6,995 Pick-up Points (PUPs). Its' customers include individual patients, hospitals and other healthcare providers and corporate customers.
The scrip has surged 79.21% from its 52-week low of Rs 1,181.80 hit on 24 March 2020. The stock hit a record high at Rs 2,180 today.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
